Cleo Fields bought Lam Research Corp (NASDAQ: LRCX)
Cleo Fields (D-LA), a U.S. Representative, has disclosed 1 trade in Lam Research Corp (LRCX) since 2026, a single purchase, worth an estimated $33K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Cleo Fields bought $15,001 - $50,000 of Lam Research Corp (NASDAQ: LRCX) on February 3, 2026. Since that trade, LRCX is up +9.80% against the S&P 500 up +6.08%, an outperformance of +3.72%.
Data updated
Cleo Fields's LRCX trades vs the price
LRCX is up +9.80% since Cleo Fields bought on February 3, 2026, versus +6.08% for the S&P 500.
Performance since this trade
All Cleo Fields LRCX trades
Cleo Fields & LRCX trading FAQ
Is it legal for Cleo Fields to trade Lam Research Corp (LRCX) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Lam Research Corp (LRCX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Cleo Fields buy LRCX?
Cleo Fields disclosed a purchase of $15,001 - $50,000 of Lam Research Corp (LRCX) on February 3, 2026, according to public STOCK Act filings.
How has LRCX performed since Cleo Fields's trade?
Since Cleo Fields bought LRCX on February 3, 2026, the stock is up +9.80%, versus +6.08% for the S&P 500 over the same period, an outperformance of +3.72%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional LRCX trades?
Quantellect tracks every disclosed congressional trade in Lam Research Corp (LRCX) on the Lam Research Corp congressional trading page, which aggregates filings across all members of Congress.
Cleo Fields's LRCX tradesAll congressional filings for Lam Research CorpCleo Fields's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.